MiRNA signatures in glioma diagnosis
Part of Cancer clinical trials.
This study looks at three specific molecules in glioma tumors to understand their role and potentially improve diagnosis. It may help people with glioma by providing more targeted information about their condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a glioma (a type of brain tumor).
- You do not have any other type of cancer at the same time.
- Your cancer has not spread to other parts of your body (no metastases).
- You have had surgery or a biopsy where tumor tissue was collected and is still available.
- You are willing to sign a consent form to participate.
- You do not have HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at whether a simple blood test that checks for tiny molecules (called miRNAs) can help monitor people with slow-growing brain tumors. If you had surgery for a grade 2 or 3 glioma at Caen University Hospital and are still being followed there, this study might be for you.
This trial studies whether changes in RNA (the instructions inside cells) can help doctors better diagnose and treat gliomas, a type of brain tumor. If you are scheduled for surgery to remove a suspected glioma and have not had prior treatment, you may be able to join.
This study looks at MRI scans to find “molecular markers” that may reflect how active a brain tumor is. If you’re having surgery for a primary brain tumor, these scan results may help researchers better understand tumor behavior.
This trial is for people with glioma who have tumor tissue or blood samples stored. It uses artificial intelligence to analyze these samples and find the best treatment. You might be eligible if you are at least 18 years old and have had a glioma diagnosis with tissue available for study.
This study looks for genetic markers from tumor cells in your blood to see if they can help track glioblastoma progression. If you have glioblastoma and standard treatment has stopped working, this test might give your doctor more information about your cancer.
This study uses brain MRI images and tumor tissue to predict the tumor’s molecular (cell-level) features in people with glioma. It may help doctors better understand glioma biology and plan care based on noninvasive imaging plus lab testing.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.